Dipeptide diaminobutyroyl benzylamide diacetate
Is Dipeptide diaminobutyroyl benzylamide diacetate legal in the US?
No prescription; it is a cosmetic ingredient.
DNo meaningful dataCosmetic ingredientas of 2026-10-26
A cosmetic ingredient, not a drug. It is used in creams and serums marketed in the US under cosmetic rules, which do not require FDA approval before sale, and it has never been reviewed or approved by the FDA for any therapeutic use. 1
No, and it does not need to be. The FDA does not pre-approve cosmetics in the US. No one has ever evaluated the ingredient as a drug. 1
Read the full Dipeptide diaminobutyroyl benzylamide diacetate page
More on Dipeptide diaminobutyroyl benzylamide diacetate
Citations
- Happi 2005: Pentapharm introduces anti-wrinkle active (Syn-Ake) happi.com
- CosmeticsDesign Europe 2007: snake venom-based anti-ageing cream launched in UK cosmeticsdesign-europe.com
- Zhu 2026, International Journal of Cosmetic Science: ex vivo and clinical studies of a serum combining dipeptide diaminobutyroyl benzylamide diacetate, acetyl hexapeptide-8 and other actives doi.org
- DSM 2020: Syn-Ake product brochure with supplier in vivo test dsm.com
Reference information only, not medical advice. Drawn from the Dipeptide diaminobutyroyl benzylamide diacetate article, fact-checked against the cited sources. No dosing anywhere on this site.